| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anion Transport Proteins | 12 | 2016 | 31 | 1.820 |
Why?
|
| COUP Transcription Factor I | 9 | 2020 | 91 | 1.280 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2023 | 236 | 1.120 |
Why?
|
| Ear, Inner | 4 | 2013 | 49 | 1.070 |
Why?
|
| Hair Cells, Auditory | 7 | 2020 | 65 | 1.050 |
Why?
|
| Cell Membrane | 8 | 2017 | 483 | 0.920 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 128 | 0.780 |
Why?
|
| Hair Cells, Auditory, Outer | 7 | 2017 | 70 | 0.730 |
Why?
|
| HIV-1 | 1 | 2023 | 489 | 0.640 |
Why?
|
| Cochlea | 11 | 2021 | 90 | 0.600 |
Why?
|
| Receptors, Steroid | 4 | 2005 | 276 | 0.530 |
Why?
|
| HIV Infections | 2 | 2023 | 2072 | 0.520 |
Why?
|
| Molecular Motor Proteins | 8 | 2017 | 29 | 0.510 |
Why?
|
| Organ of Corti | 5 | 2013 | 26 | 0.500 |
Why?
|
| DNA-Binding Proteins | 10 | 2005 | 2145 | 0.490 |
Why?
|
| Transcription Factors | 9 | 2005 | 2720 | 0.420 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2013 | 1051 | 0.410 |
Why?
|
| Membrane Microdomains | 3 | 2009 | 63 | 0.400 |
Why?
|
| Animals | 48 | 2021 | 36215 | 0.390 |
Why?
|
| Mice | 36 | 2021 | 18935 | 0.390 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 398 | 0.380 |
Why?
|
| Antioxidants | 1 | 2015 | 366 | 0.380 |
Why?
|
| Hyperkinesis | 1 | 2012 | 27 | 0.370 |
Why?
|
| Deafness | 2 | 2012 | 86 | 0.370 |
Why?
|
| Evolution, Molecular | 4 | 2015 | 707 | 0.370 |
Why?
|
| Receptor, Adenosine A2B | 2 | 2021 | 11 | 0.360 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 157 | 0.350 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2651 | 0.320 |
Why?
|
| Gerbillinae | 5 | 2016 | 49 | 0.310 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2021 | 159 | 0.310 |
Why?
|
| Trehalose | 2 | 2018 | 21 | 0.280 |
Why?
|
| Electric Capacitance | 3 | 2016 | 15 | 0.280 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 384 | 0.270 |
Why?
|
| Directed Molecular Evolution | 1 | 2006 | 11 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 4823 | 0.260 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2015 | 396 | 0.260 |
Why?
|
| Patch-Clamp Techniques | 6 | 2016 | 300 | 0.260 |
Why?
|
| Hearing Loss | 4 | 2017 | 214 | 0.250 |
Why?
|
| MicroRNAs | 1 | 2013 | 945 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 5 | 2017 | 403 | 0.250 |
Why?
|
| Crassostrea | 1 | 2015 | 4 | 0.240 |
Why?
|
| Receptors, Notch | 2 | 2006 | 214 | 0.230 |
Why?
|
| Membrane Potentials | 4 | 2017 | 316 | 0.220 |
Why?
|
| Receptors, Androgen | 6 | 1995 | 433 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2013 | 2026 | 0.210 |
Why?
|
| Chromosome Disorders | 2 | 2018 | 313 | 0.210 |
Why?
|
| Protein Transport | 4 | 2015 | 389 | 0.200 |
Why?
|
| Mice, Knockout | 11 | 2020 | 3979 | 0.200 |
Why?
|
| Molecular Sequence Data | 9 | 2015 | 3960 | 0.200 |
Why?
|
| Astrocytes | 3 | 2021 | 272 | 0.200 |
Why?
|
| Gene Expression | 5 | 2020 | 1608 | 0.200 |
Why?
|
| Embryonic and Fetal Development | 4 | 2001 | 136 | 0.190 |
Why?
|
| beta-Galactosidase | 2 | 2007 | 148 | 0.190 |
Why?
|
| Genome-Wide Association Study | 1 | 2010 | 1838 | 0.190 |
Why?
|
| Cholesterol | 4 | 2009 | 572 | 0.190 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 1993 | 45 | 0.190 |
Why?
|
| Stria Vascularis | 1 | 2021 | 4 | 0.180 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2001 | 4 | 0.180 |
Why?
|
| Auditory Pathways | 1 | 2021 | 20 | 0.180 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 214 | 0.180 |
Why?
|
| Electrophysiology | 4 | 2016 | 281 | 0.170 |
Why?
|
| Mediator Complex | 1 | 2021 | 61 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2024 | 477 | 0.170 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2024 | 264 | 0.170 |
Why?
|
| Androgen-Binding Protein | 2 | 1991 | 26 | 0.170 |
Why?
|
| Biotinylation | 2 | 2011 | 23 | 0.170 |
Why?
|
| Epithelial Cells | 1 | 2005 | 932 | 0.170 |
Why?
|
| Erythrocytes | 1 | 2021 | 232 | 0.170 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 17 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 415 | 0.160 |
Why?
|
| Humans | 34 | 2024 | 133269 | 0.160 |
Why?
|
| Cell Line | 8 | 2008 | 2853 | 0.160 |
Why?
|
| Skin | 4 | 1993 | 542 | 0.160 |
Why?
|
| Hypoxia | 1 | 2021 | 267 | 0.160 |
Why?
|
| Virulence Factors | 1 | 2020 | 187 | 0.150 |
Why?
|
| Base Sequence | 6 | 2018 | 3153 | 0.150 |
Why?
|
| HEK293 Cells | 3 | 2017 | 824 | 0.150 |
Why?
|
| Aging | 3 | 2021 | 1280 | 0.150 |
Why?
|
| COUP Transcription Factors | 4 | 2005 | 43 | 0.150 |
Why?
|
| Acetylglucosaminidase | 1 | 2018 | 12 | 0.150 |
Why?
|
| Proteins | 6 | 2013 | 1090 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 189 | 0.150 |
Why?
|
| Cells, Cultured | 7 | 2017 | 3131 | 0.150 |
Why?
|
| Transfection | 4 | 2009 | 1095 | 0.150 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 13 | 0.140 |
Why?
|
| COUP Transcription Factor II | 4 | 2005 | 117 | 0.140 |
Why?
|
| Diflunisal | 1 | 2017 | 1 | 0.140 |
Why?
|
| Memory Disorders | 1 | 2020 | 235 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 1 | 1999 | 225 | 0.140 |
Why?
|
| Alleles | 4 | 2017 | 1697 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2020 | 288 | 0.140 |
Why?
|
| Green Fluorescent Proteins | 5 | 2009 | 402 | 0.140 |
Why?
|
| Endopeptidases | 1 | 2018 | 119 | 0.140 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 474 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2017 | 2523 | 0.130 |
Why?
|
| Chlorides | 1 | 2017 | 108 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 805 | 0.130 |
Why?
|
| Retinal Degeneration | 1 | 2018 | 103 | 0.130 |
Why?
|
| Repressor Proteins | 3 | 2013 | 872 | 0.130 |
Why?
|
| Autophagy | 2 | 2018 | 431 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 317 | 0.130 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 1995 | 27 | 0.130 |
Why?
|
| Ion Transport | 1 | 2016 | 54 | 0.130 |
Why?
|
| Hippocampus | 2 | 2020 | 861 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 53 | 0.130 |
Why?
|
| Amino Acid Sequence | 5 | 2015 | 2785 | 0.130 |
Why?
|
| Time Factors | 3 | 2016 | 6544 | 0.120 |
Why?
|
| Kidney | 3 | 2009 | 1394 | 0.120 |
Why?
|
| Doxycycline | 1 | 2016 | 121 | 0.120 |
Why?
|
| Neurons | 6 | 2017 | 2050 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 884 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 169 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 313 | 0.120 |
Why?
|
| Models, Biological | 3 | 2013 | 1531 | 0.120 |
Why?
|
| Texas | 1 | 2023 | 3664 | 0.110 |
Why?
|
| Movement Disorders | 1 | 2017 | 223 | 0.110 |
Why?
|
| Inflammation | 2 | 2021 | 1557 | 0.110 |
Why?
|
| Heart | 1 | 1999 | 712 | 0.110 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2013 | 6 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2009 | 356 | 0.110 |
Why?
|
| Chromosome Deletion | 2 | 2018 | 664 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 511 | 0.110 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 4 | 2021 | 25 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 284 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2018 | 689 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2016 | 312 | 0.100 |
Why?
|
| Embryo, Mammalian | 3 | 2013 | 467 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 180 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 120 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2021 | 806 | 0.100 |
Why?
|
| Seizures | 1 | 2018 | 889 | 0.100 |
Why?
|
| Cochlear Microphonic Potentials | 2 | 2013 | 8 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 431 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2021 | 439 | 0.100 |
Why?
|
| Receptors, Ghrelin | 1 | 2012 | 29 | 0.100 |
Why?
|
| Brain | 3 | 2021 | 3224 | 0.100 |
Why?
|
| Ghrelin | 1 | 2012 | 55 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 411 | 0.090 |
Why?
|
| Disease Progression | 1 | 2018 | 2246 | 0.090 |
Why?
|
| Body Patterning | 1 | 2012 | 131 | 0.090 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 3 | 2021 | 11 | 0.090 |
Why?
|
| Alcohol Dehydrogenase | 1 | 1991 | 22 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2013 | 714 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2013 | 225 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1362 | 0.090 |
Why?
|
| Leptin | 1 | 2012 | 222 | 0.090 |
Why?
|
| Membrane Lipids | 2 | 2008 | 31 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2018 | 1094 | 0.080 |
Why?
|
| Protein Structure, Secondary | 2 | 2009 | 256 | 0.080 |
Why?
|
| Cysteine | 2 | 2009 | 143 | 0.080 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2009 | 12 | 0.080 |
Why?
|
| Binding Sites | 2 | 2010 | 1378 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2017 | 839 | 0.080 |
Why?
|
| Hearing | 2 | 2007 | 62 | 0.080 |
Why?
|
| Glycosylation | 1 | 2009 | 129 | 0.080 |
Why?
|
| Markov Chains | 1 | 2010 | 99 | 0.080 |
Why?
|
| Mutation | 7 | 2010 | 6343 | 0.080 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2010 | 158 | 0.080 |
Why?
|
| Structure-Activity Relationship | 2 | 2009 | 607 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 415 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2009 | 1611 | 0.070 |
Why?
|
| Male | 15 | 2021 | 65527 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2008 | 605 | 0.070 |
Why?
|
| Fibroblasts | 6 | 2017 | 890 | 0.070 |
Why?
|
| Fluorescent Dyes | 2 | 2007 | 268 | 0.070 |
Why?
|
| Helper Viruses | 1 | 2007 | 46 | 0.070 |
Why?
|
| Glucose | 1 | 2012 | 917 | 0.070 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2007 | 96 | 0.070 |
Why?
|
| Renilla | 1 | 2006 | 3 | 0.070 |
Why?
|
| Intracellular Membranes | 1 | 2007 | 65 | 0.070 |
Why?
|
| Signal Transduction | 5 | 2020 | 4918 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1325 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2013 | 982 | 0.070 |
Why?
|
| Organic Anion Transporters | 1 | 2006 | 21 | 0.070 |
Why?
|
| Endosomes | 1 | 2007 | 68 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1152 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2007 | 97 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 841 | 0.060 |
Why?
|
| Phylogeny | 2 | 2015 | 780 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2007 | 74 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1067 | 0.060 |
Why?
|
| Glycosyltransferases | 1 | 2006 | 27 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 94 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2006 | 62 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3363 | 0.060 |
Why?
|
| Female | 12 | 2024 | 71454 | 0.060 |
Why?
|
| Behavior, Animal | 2 | 2020 | 522 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2007 | 361 | 0.060 |
Why?
|
| Endoplasmic Reticulum | 1 | 2007 | 229 | 0.060 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 72 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2006 | 432 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 1830 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 174 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 1582 | 0.060 |
Why?
|
| Guanine | 1 | 2005 | 62 | 0.060 |
Why?
|
| Genitalia | 3 | 1990 | 39 | 0.060 |
Why?
|
| Ovalbumin | 2 | 1996 | 321 | 0.060 |
Why?
|
| Trans-Activators | 2 | 2000 | 835 | 0.060 |
Why?
|
| Adenine | 1 | 2005 | 123 | 0.060 |
Why?
|
| RNA, Messenger | 5 | 2013 | 2877 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2015 | 299 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2005 | 104 | 0.060 |
Why?
|
| Protein Binding | 2 | 2015 | 1852 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 1136 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2017 | 127 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2005 | 1730 | 0.050 |
Why?
|
| Triglycerides | 1 | 2006 | 616 | 0.050 |
Why?
|
| Molecular Weight | 4 | 1991 | 384 | 0.050 |
Why?
|
| Serine | 2 | 2017 | 185 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1714 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2009 | 1597 | 0.050 |
Why?
|
| Genitalia, Male | 2 | 1993 | 39 | 0.050 |
Why?
|
| Gene Targeting | 2 | 2001 | 185 | 0.050 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 2021 | 3 | 0.050 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2021 | 6 | 0.050 |
Why?
|
| Bisphosphoglycerate Mutase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Cytosol | 2 | 1993 | 167 | 0.050 |
Why?
|
| Phenotype | 4 | 2018 | 4577 | 0.050 |
Why?
|
| Reflex, Startle | 1 | 2021 | 34 | 0.050 |
Why?
|
| Tissue Preservation | 1 | 2001 | 16 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2021 | 53 | 0.040 |
Why?
|
| Limb Buds | 1 | 2001 | 7 | 0.040 |
Why?
|
| Tail | 1 | 2001 | 14 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 139 | 0.040 |
Why?
|
| Spiral Ganglion | 1 | 2000 | 10 | 0.040 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2000 | 43 | 0.040 |
Why?
|
| Choristoma | 1 | 2001 | 46 | 0.040 |
Why?
|
| Drug Resistance | 2 | 1993 | 262 | 0.040 |
Why?
|
| Glycolysis | 1 | 2021 | 173 | 0.040 |
Why?
|
| Vestibule, Labyrinth | 1 | 2000 | 44 | 0.040 |
Why?
|
| Random Allocation | 1 | 2021 | 443 | 0.040 |
Why?
|
| Nerve Fibers | 1 | 2020 | 76 | 0.040 |
Why?
|
| Obesity | 1 | 2012 | 2440 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 240 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 151 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 640 | 0.040 |
Why?
|
| Fear | 1 | 2021 | 205 | 0.040 |
Why?
|
| Microglia | 1 | 2021 | 139 | 0.040 |
Why?
|
| Myelin Sheath | 1 | 2020 | 127 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 252 | 0.040 |
Why?
|
| Adenosine | 1 | 2020 | 140 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 592 | 0.040 |
Why?
|
| Thalamus | 1 | 1999 | 89 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1999 | 128 | 0.040 |
Why?
|
| Genotype | 1 | 2005 | 2720 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2559 | 0.040 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2018 | 13 | 0.040 |
Why?
|
| Vacuoles | 1 | 2018 | 29 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 500 | 0.040 |
Why?
|
| Syndrome | 2 | 1993 | 1174 | 0.040 |
Why?
|
| Retinal Bipolar Cells | 1 | 2018 | 40 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2011 | 787 | 0.040 |
Why?
|
| Axons | 2 | 1999 | 397 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 548 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1997 | 215 | 0.040 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2018 | 88 | 0.030 |
Why?
|
| Glossopharyngeal Nerve | 1 | 1997 | 5 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2018 | 61 | 0.030 |
Why?
|
| Ganglia | 1 | 1997 | 20 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 902 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 1991 | 677 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 366 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2013 | 1041 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 149 | 0.030 |
Why?
|
| Biomarkers | 1 | 2007 | 3416 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 127 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 42 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 110 | 0.030 |
Why?
|
| Macrophages | 1 | 2021 | 697 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1999 | 481 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 4758 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 266 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2017 | 1706 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 173 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 174 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 562 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 400 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 1997 | 1420 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3735 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 1999 | 540 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 521 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1584 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2007 | 391 | 0.030 |
Why?
|
| Synapses | 1 | 2018 | 470 | 0.030 |
Why?
|
| Noise | 1 | 2013 | 21 | 0.030 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2013 | 4 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 358 | 0.030 |
Why?
|
| Immunochemistry | 2 | 1990 | 24 | 0.030 |
Why?
|
| Ethylnitrosourea | 1 | 2013 | 7 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 896 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 167 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 120 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 946 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 151 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 160 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2012 | 75 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1993 | 228 | 0.020 |
Why?
|
| Disorders of Sex Development | 1 | 1992 | 72 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 960 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 377 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 226 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2011 | 20 | 0.020 |
Why?
|
| Biotin | 1 | 2011 | 48 | 0.020 |
Why?
|
| Poly A | 1 | 1991 | 59 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 1033 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1991 | 269 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1991 | 395 | 0.020 |
Why?
|
| Gene Library | 1 | 1991 | 224 | 0.020 |
Why?
|
| Tectorial Membrane | 1 | 2010 | 5 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 42 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2002 | 453 | 0.020 |
Why?
|
| Epilepsy | 1 | 2018 | 897 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 242 | 0.020 |
Why?
|
| DNA | 2 | 1997 | 1676 | 0.020 |
Why?
|
| Affinity Labels | 1 | 1989 | 13 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 67 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9917 | 0.020 |
Why?
|
| Disulfides | 1 | 2009 | 84 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 1989 | 73 | 0.020 |
Why?
|
| Metabolome | 1 | 2012 | 322 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 108 | 0.020 |
Why?
|
| Valine | 1 | 2009 | 114 | 0.020 |
Why?
|
| Connexins | 1 | 2009 | 64 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1035 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2008 | 90 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 656 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 160 | 0.020 |
Why?
|
| Cell Death | 2 | 1999 | 248 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 748 | 0.020 |
Why?
|
| Lac Operon | 1 | 2007 | 96 | 0.020 |
Why?
|
| Electrodes | 1 | 2007 | 91 | 0.020 |
Why?
|
| Haplotypes | 1 | 2009 | 545 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 2007 | 18 | 0.020 |
Why?
|
| RNA | 1 | 1991 | 606 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 297 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2008 | 911 | 0.020 |
Why?
|
| Epithelium | 1 | 2007 | 354 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 176 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2007 | 261 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 2952 | 0.020 |
Why?
|
| Androgens | 1 | 1988 | 300 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 255 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 814 | 0.020 |
Why?
|
| Hair Cells, Vestibular | 1 | 2005 | 11 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2005 | 66 | 0.010 |
Why?
|
| Middle Aged | 2 | 2024 | 28952 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2005 | 75 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2005 | 99 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 906 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 317 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 130 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2002 | 1757 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 631 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 2 | 1995 | 49 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 243 | 0.010 |
Why?
|
| Presenilin-2 | 1 | 2003 | 19 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2003 | 57 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 31648 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2005 | 378 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 26 | 0.010 |
Why?
|
| Exons | 1 | 2005 | 825 | 0.010 |
Why?
|
| Zebrafish | 1 | 2005 | 422 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 61 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2009 | 3417 | 0.010 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2002 | 76 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2001 | 11 | 0.010 |
Why?
|
| Somites | 1 | 2001 | 9 | 0.010 |
Why?
|
| Cochlear Duct | 1 | 2000 | 5 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 87 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2000 | 53 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2000 | 86 | 0.010 |
Why?
|
| Fetal Death | 1 | 2001 | 120 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 257 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2092 | 0.010 |
Why?
|
| Carbocyanines | 1 | 1999 | 14 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 396 | 0.010 |
Why?
|
| Brain Stem | 1 | 2000 | 119 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 59 | 0.010 |
Why?
|
| Antimetabolites | 1 | 1999 | 33 | 0.010 |
Why?
|
| Pedigree | 2 | 1995 | 1729 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2009 | 5199 | 0.010 |
Why?
|
| Postural Balance | 1 | 2000 | 132 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 624 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 3851 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1997 | 7 | 0.010 |
Why?
|
| Okadaic Acid | 1 | 1997 | 14 | 0.010 |
Why?
|
| Oxazoles | 1 | 1997 | 23 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1999 | 283 | 0.010 |
Why?
|
| Rhombencephalon | 1 | 1997 | 50 | 0.010 |
Why?
|
| Neural Crest | 1 | 1997 | 56 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 1997 | 268 | 0.010 |
Why?
|
| Sequence Homology | 1 | 1996 | 64 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1996 | 97 | 0.010 |
Why?
|
| Chickens | 1 | 1996 | 639 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1995 | 8 | 0.010 |
Why?
|
| Manitoba | 1 | 1995 | 3 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 563 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1995 | 141 | 0.010 |
Why?
|
| Genetic Carrier Screening | 1 | 1995 | 72 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 606 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 470 | 0.010 |
Why?
|
| X Chromosome | 1 | 1995 | 341 | 0.010 |
Why?
|
| Apoptosis | 1 | 2000 | 1928 | 0.010 |
Why?
|
| Histidine | 1 | 1992 | 75 | 0.010 |
Why?
|
| Canada | 1 | 1992 | 343 | 0.010 |
Why?
|
| Photofluorography | 1 | 1989 | 1 | 0.010 |
Why?
|
| Arginine | 1 | 1992 | 350 | 0.010 |
Why?
|
| Photochemistry | 1 | 1989 | 22 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1989 | 27 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1989 | 46 | 0.000 |
Why?
|
| Pregnancy | 1 | 2002 | 7596 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1989 | 316 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1988 | 18 | 0.000 |
Why?
|
| Estrenes | 1 | 1988 | 21 | 0.000 |
Why?
|
| Photolysis | 1 | 1988 | 12 | 0.000 |
Why?
|
| Metribolone | 1 | 1988 | 31 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1989 | 1049 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1995 | 14859 | 0.000 |
Why?
|
| Adolescent | 1 | 1992 | 20547 | 0.000 |
Why?
|